On July 2, JD Health rose 3.78% in regular trading, trading at 34.16 HKD/share, with turnover of approximately 98.94 million HKD.

On the news front, the broader Hong Kong market strengthened notably, with the Hang Seng Index expanding gains and technology, pharmaceutical, and insurance sectors all posting positive performance. Within the Internet and Direct Marketing Retail sector, Meituan rose 6.13%, JD Group rose 4.99%, Ali Health rose 4.22%, and Alibaba rose 3.12%, reflecting broad-based sector momentum.

Additionally, JD Health resumed its daily 500,000-share buyback pace on June 30, spending approximately 16.39 million HKD at prices between 32.40 and 33.00 HKD per share. This follows a brief reduction on June 29 when only 101,700 shares were repurchased, which had previously raised market concerns about weakening shareholder support. Year-to-date, the company has conducted 24 buybacks totaling approximately 21.54 million shares, with cumulative spending of around 839 million HKD, signaling sustained management confidence in the company's intrinsic value.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)